Conference Coverage: ASCO 2021 – FOCUS ON BREAST CANCER

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making coming out of the ASCO 2021 conference.

June 10, 2021

FACULTY CHAIR

Adam Brufsky, MD, PhD

Magee-Womens Cancer Program at the UPMC Hillman Cancer Center, Pittsburgh, PA, USA

FACULTY MEMBERS

Giuseppe Curigliano, MD, PhD
University of Milano, Milan, Italy

William Gradishar, MD
Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Nadia Harbeck, MD, PhD
Ludwig-Maximilians-University of Munich LMU – Breast Center, Germany

Mark D. Pegram, MD
Stanford Cancer Institute, Stanford, CA, USA

Paul Ellis, MD, FRACP
The London Breast Clinic, London, UK

Guy H. Jerusalem, MD, PhD
University of Liège, Liège, Belgium

Peter A. Kaufman, MD
The University of Vermont Medical Center, Burlington, VT, USA

Agenda

Export meeting topics

View Agenda

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Updates of Neoadjuvant Therapies in BC
  • CDK4/6 Inhibitors in the Treatment of HR+/HER2– Breast Cancer
  • Novel Therapeutic Approaches for HR+/HER2– Breast Cancer
  • Evolving Treatments for HER2+/HR– Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.